Mega Genomics Limited (HKG:6667)
Hong Kong · Delayed Price · Currency is HKD 7.19
+0.02 (0.28%)
Sep 11, 2026, 3:51 PM HKT
Mega Genomics Market Cap
Mega Genomics has a market cap or net worth of 1.61 billion as of September 10, 2026. Its market cap has decreased by -0.43% in one year.
Market Cap
1.61B
Enterprise Value
1.15B
Revenue
413.73M
Ranking
n/a
PE Ratio
50.03
Stock Price
7.19
ChartMarket Cap Chart
Since June 22, 2022, Mega Genomics's market cap has decreased from 4.31B to 1.61B, a decrease of -62.66%. That is a compound annual growth rate of -20.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.61B | -35.80% |
| Dec 31, 2024 | 2.50B | 2.28% |
| Dec 29, 2023 | 2.45B | -21.25% |
| Dec 30, 2022 | 3.11B | -27.78% |
| Jun 22, 2022 | 4.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 94.60B |
| Adicon Holdings | 2.85B |
| Guanze Medical Information Industry (Holding) | 2.24B |
| Kindstar Globalgene Technology | 915.34M |
| China Biotech Services Holdings | 619.59M |
| Biosino Bio-Technology and Science Incorporation | 474.64M |
| China NT Pharma Group Company | 379.60M |
| Yunkang Group | 307.31M |